Back to Results
First PageMeta Content
Oncology / Orphan drugs / Myelodysplastic syndrome / Syndromes / Azacitidine / Decitabine / Cyclacel / Medicine / Nucleosides / Triazines


June 14, 2013 Astex Pharmaceuticals Announces Presentation of Updated Results of SGI[removed]Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology As
Add to Reading List

Open Document

File Size: 24,02 KB

Share Result on Facebook
UPDATE